previous compound ID: 1079 next compound
InChIKey: JLKIGFTWXXRPMT-UHFFFAOYSA-N
SMILES: CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Goepp" "D Rotin" "SD Macknight" "GW Carlile" "JW Hanrahan" "R Robert" "J Liao" "DY Thomas" "B Kus" "E Matthes"

chemical graph of compound 1079





CID is 5329
synonyms found at PubChem are:
sulfamethoxazole, 723-46-6, Gantanol, Sulphamethoxazole, Sulfisomezole, Sulfamethoxazol, Metoxal, Sulfamethylisoxazole, Simsinomin, Radonil, Sinomin, Sulphamethoxazol, 4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide, Sulpha-methoxizole, Sulfamethalazole, Azo-gantanol, Sulphamethylisoxazole, Urobak, Sulfamethoxizole, 3-Sulfanilamido-5-methylisoxazole, Gantanol-DS, 4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide, Bactrimel, Gamazole, Sulfametoxazol, Sulphisomezole, Solfametossazolo, Sulfamethoxazolum, 5-Methyl-3-sulfanilamidoisoxazole, Ro 4-2130, MS 53, 3-Sulphanilamido-5-methylisoxazole, 5-Methyl-3-sulphanil-amidoisoxazole, 3-(p-Aminophenylsulfonamido)-5-methylisoxazole, Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-, 5-Methyl-3-sulfanylamidoisoxazole, Azo gantanol, N'-(5-Methyl-3-isoxazolyl)sulfanilamide, N1-(5-Methyl-3-isoxazolyl)sulfanilamide, N'-(5-Methylisoxazol-3-yl)sulphanilamide, 4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide, Solfametossazolo [DCIT], 3-(para-Aminophenylsulphonamido)-5-methylisoxazole, Sulfametoxazol [INN-Spanish], Sulfamethoxazolum [INN-Latin], Septran, Trib, Sulphamethalazole, A047, Sulfamethoxazole sodium, UNII-JE42381TNV, Apo-Sulfamethoxazole, CCRIS 567, N(sup 1)-(5-Methyl-3-isoxazolyl)sulphanilamide, CHEBI:9332, N'-(5-Methyl-3-isoxazole)sulfanilamide, HSDB 3186, Ro 6-2580/11, Sulfamethoxazole [USAN:INN:JAN], Sulfanilamide, N'-(5-methyl-3-isoxazolyl)-, Sulfanilamide, N1-(5-methyl-3-isoxazolyl)-, Sulphamethoxazole BP 98, EINECS 211-963-3, SMX, CHEMBL443, NSC 147832, BRN 0226453, 4-Amino-N-(5-methyl-isoxazol-3-yl)-benzenesulfonamide, MLS000069732, JE42381TNV, 4-AMINO-N-(5-METHYL-3-ISOXAZOYL)BENZENESULFONAMIDE, 4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzene-1-sulfonamide, C10H11N3O3S, N(sup1)-(5-Methyl-3-isoxazolyl)sulfanilamide, 5-Methyl-3-sulfonylamidoisoxazole, JLKIGFTWXXRPMT-UHFFFAOYSA-N, N(sup 1)-(5-Methyl-3-isoxazolyl)sulfanilamide, Sulfanilamide, N(1)-(5-methyl-3-isoxazolyl)-, ALBB-002089, NSC147832, NCGC00016533-05, NCGC00186654-01, CAS-723-46-6, N1-(5-Methylisoxazol-3-yl)sulfanilamide, SMR000058223, DSSTox_CID_6064, 3-(p-Aminobenzenesulfonamido)-5-methylisoxazole, DSSTox_RID_78001, DSSTox_GSID_26064, 4-Amino-N-[5-methyl-3-isoxazolyl]benzenesulfonamide, [(4-aminophenyl)sulfonyl](5-methylisoxazol-3-yl)amine, 4-Amino-N-(5-methyl-3-isoxazolyl)-benzenesulfonamide, N1-(5-methylisoxazol-3-yl)-4-aminobenzene-1-sulfonamide, 129378-89-8, SR-01000000217, Gantanol DS, Sulphameth oxazole, DRG-0031, Prestwick_453, Septrin (TN), Septran (Salt/Mix), Septrin (Salt/Mix), Sulfamethoxazole,(S), Eusaprim (Salt/Mix), Spectrum_000994, Sulfamethoxazole(USAN), Opera_ID_882, Maybridge1_007190, Prestwick0_000177, Prestwick1_000177, Prestwick2_000177, Prestwick3_000177, Spectrum2_000788, Spectrum3_000584, Spectrum4_000345, Spectrum5_000982, Sulfamethoxazole [USAN:USP:INN:BAN:JAN], D0AE2X, D0R9OH, Epitope ID:114999, Co-trimoxazole (Salt/Mix), AC1Q2J5R, SCHEMBL3656, Oprea1_114486, Oprea1_285680, BSPBio_000073, BSPBio_002028, KBioGR_000749, KBioSS_001474, KSC635S5T, MLS001055354, MLS001074165, MLS006011871, BIDD:GT0731, DivK1c_000649, SPECTRUM1500550, SPBio_000896, SPBio_001994, AC1L1K42, ARONIS018156, BPBio1_000081, DTXSID8026064, component of Bactrim (Salt/Mix), CTK5D5959, HMS502A11, HMS561O18, JLKIGFTWXXRPMT-UHFFFAOYSA-, KBio1_000649, KBio2_001474, KBio2_004042, KBio2_006610, KBio3_001528, KS-00004AEJ, ZINC89763, EBD3403, WLN: T5NOJ C1 EMSWR DZ, MolPort-000-145-787, NINDS_000649, HMS1568D15, HMS1921A21, HMS2092K03, HMS2095D15, HMS2233L13, HMS3259E06, HMS3372M22, HMS3655O22, HMS3712D15, Pharmakon1600-01500550, BCP02881, HY-B0322, KS-000000QU, Sulfamethoxazole (JP15/USP/INN), Sulfamethoxazole (JP17/USP/INN), Sulfamethoxazole, analytical standard, Tox21_110480, Tox21_200353, ANW-43073, BBL004554, BDBM50029770, CCG-40166, HTS001394, KM1475, MFCD00010546, NSC757328, Ro-42130, s1915, SBB057675, SBB071655, STK007988, AKOS000200952, component of Azo Gantanol (Salt/Mix), Tox21_110480_1, BS-3542, CS-2363, DB01015, LS-1620, MCULE-1450176600, NC00537, NSC-147832, NSC-757328, Ro-4-2130, RTR-023663, TRA0076970, IDI1_000649, NCGC00016533-01, NCGC00016533-02, NCGC00016533-03, NCGC00016533-04, NCGC00016533-06, NCGC00016533-07, NCGC00016533-08, NCGC00016533-09, NCGC00016533-10, NCGC00016533-11, NCGC00016533-12, NCGC00016533-14, NCGC00021995-03, NCGC00021995-04, NCGC00021995-05, NCGC00257907-01, AC-11118, AN-22110, BAS 00836086, CPD000058223, H463, KB-97587, SAM002554930, SC-15160, ST024740, BCP0726000283, N'-(5-Methyl-3-isoxazolyl)-Sulfanilamide, N1-(5-methyl-3-isoxazolyl)-Sulfanilamide, N1-(5-Methyl-3-isoxazolyl)sulphanilamide, SBI-0051524.P003, AB1009297, ST2418109, TL8005058, AB00052099, BB 0242379, FT-0602616, N(1)-(5-Methyl-3-isoxazolyl)sulphanilamide, N^1-(5-Methyl-3-isoxazolyl)-Sulfanilamide, S0361, ST51006798, C07315, D00447, J10090, 4-[N-(5-Methylisoxazol-3-yl)sulphamoyl]aniline, AB00052099-14, AB00052099-16, AB00052099_17, AB00052099_18, Ndimethyl1-(5-methyl-3-isoxazolyl)-Sulfanilamide, I01-0154, Q-201762, SR-01000000217-2, SR-01000000217-3, Sulfamethoxazole, VETRANAL(TM), analytical standard, Sulfanilamide, N1-(5-methyl-3-isoxazolyl)- (8CI), Sulfanilamide, N1-(5-methyl-3-isoxazolyl)-(8CI), 4-Amino-N-[5-methyl-3- isoxazolyl]benzenesulfonamide, BRD-K28494619-001-05-0, BRD-K28494619-001-15-9, BRD-K28494619-001-26-6, Z57198677, 4-Amino-N-(5-methyl-isoxazol-3-yl)-benzene sulfonamide, 4-AMINO-N-[5-METHYL-3-ISOXAZOLYL]BENZENESULFONAMID, Sulfamethoxazole, certified reference material, TraceCERT(R), SULFAMETHOXAZOLE (8064-90-2 (TRIMETHOPRIM/SULFAMETHOXAZOLE), Sulfamethoxazole, European Pharmacopoeia (EP) Reference Standard, Sulfamethoxazole, United States Pharmacopeia (USP) Reference Standard, SULFAMETHOXAZOLE (8064-90-2 (TRIMETHOPRIM/SULFAMETHOXAZOLE); TMP/SMX (MIXTURE)), Sulfamethoxazole, Pharmaceutical Secondary Standard; Certified Reference Material, 08D, 4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide; N1-(5-Methylisoxazol-3-yl)sulfanilamide, InChI=1/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)